ARTICLE | Company News
Dynogen, Apex Bioventures Acquisition Corp. deal
April 21, 2008 7:00 AM UTC
Special purpose acquisition company Apex and Dynogen terminated a deal under which Apex would have acquired Dynogen for $98 million in stock. The companies said they did not expect to attain sharehold...